---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-040955"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T07:16:06.138438+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics sets 2024 Annual Meeting for July 29, 2024; updates stockholder proposal deadlines

## Summary
- Annual Meeting scheduled for July 29, 2024; record date set as June 6, 2024.
- Stockholder proposals under Rule 14a-8 must be received by May 20, 2024.
- Director nominations and other proposals not included in proxy also due by May 20, 2024.
- Universal proxy rule compliance notice due by May 30, 2024 (60 days before meeting).

## SEC filing metadata
- accession: 0001213900-24-040955
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08, 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390024040955/0001213900-24-040955-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390024040955/ea020556601-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-040955
- JSON: https://secwatch.observer/filing/0001213900-24-040955.json
- Plain text: https://secwatch.observer/filing/0001213900-24-040955.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.